Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Wolf

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Pathology|January 1, 1983
Diagnostic information derived from immunotyping 1000 patients with leukemia and lymphomaD G Jose, G R Pilkington, M M Wolf, et al.
Leukemia|November 7, 2008
Stem cell factor and high-dose twice daily filgrastim is an effective strategy for peripheral blood stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine: results of a Phase II study with an historical comparatorK E Herbert, S Morgan, H M Prince, et al.
Blood|February 1, 1988
Clinical factors influencing the efficacy of pooled platelet transfusionsJ F Bishop, K McGrath, M M Wolf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin's lymphoma. The Australian and New Zealand Lymphoma GroupI A Cooper, M M Wolf, T I Robertson, et al.
Cancer Treatment Reports|December 1, 1987
Oral idarubicin as single-agent treatment of acute nonlymphocytic leukemia in poor-risk patientsR M Lowenthal, C N Chesterman, J D Griffiths, et al.
American Journal of Veterinary Research|April 1, 1995
Comparison of the sensitivity of the caudal fold skin test and a commercial gamma-interferon assay for diagnosis of bovine tuberculosisD L Whipple, C A Bolin, A J Davis, et al.
Blood|March 1, 1996
A randomized study of high-dose cytarabine in induction in acute myeloid leukemiaJ F Bishop, J P Matthews, G A Young, et al.
Leukemia & Lymphoma|September 24, 1999
A phase I/II study of intensive dose escalation of cytarabine in combination with idarubicin and etoposide in induction and consolidation treatment of adult acute myeloid leukemia. Australian Leukaemia Study Group (ALSG)R M Lowenthal, K F Bradstock, J P Matthews, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Pathology|January 1, 1983
Diagnostic information derived from immunotyping 1000 patients with leukemia and lymphomaD G Jose, G R Pilkington, M M Wolf, et al.
Leukemia|November 7, 2008
Stem cell factor and high-dose twice daily filgrastim is an effective strategy for peripheral blood stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine: results of a Phase II study with an historical comparatorK E Herbert, S Morgan, H M Prince, et al.
Blood|February 1, 1988
Clinical factors influencing the efficacy of pooled platelet transfusionsJ F Bishop, K McGrath, M M Wolf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin's lymphoma. The Australian and New Zealand Lymphoma GroupI A Cooper, M M Wolf, T I Robertson, et al.
Cancer Treatment Reports|December 1, 1987
Oral idarubicin as single-agent treatment of acute nonlymphocytic leukemia in poor-risk patientsR M Lowenthal, C N Chesterman, J D Griffiths, et al.
American Journal of Veterinary Research|April 1, 1995
Comparison of the sensitivity of the caudal fold skin test and a commercial gamma-interferon assay for diagnosis of bovine tuberculosisD L Whipple, C A Bolin, A J Davis, et al.
Blood|March 1, 1996
A randomized study of high-dose cytarabine in induction in acute myeloid leukemiaJ F Bishop, J P Matthews, G A Young, et al.
Leukemia & Lymphoma|September 24, 1999
A phase I/II study of intensive dose escalation of cytarabine in combination with idarubicin and etoposide in induction and consolidation treatment of adult acute myeloid leukemia. Australian Leukaemia Study Group (ALSG)R M Lowenthal, K F Bradstock, J P Matthews, et al.
Pageof 7